MARIA RIVAS-TORRES: Open Payments
NPI 1942465505 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 18 payments from 6 companies in 2025. Trend: 2023 $22 · 2024 $379 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $99 |
| Luye Pharma (USA) Ltd. | 4 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Alkermes, Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, ARISTADA, UZEDY, AUSTEDO XR, ABILIFY MAINTENA, REXULTI, COBENFY.
Industry payments across FL — which companies pay providers there.
